The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
The initiative aims to connect startups and tech companies with its business units,
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Tinostamustine is an investigational drug with a potential first-in-class mechanism combining bifunctional alkylating activity and pan histone deacetylase (HDAC) inhibition
Subscribe To Our Newsletter & Stay Updated
